These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7268897)

  • 1. Heterogeneity of natural killer cells in the mouse.
    Burton RC; Bartlett SP; Kumar V; Winn HJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):783-6. PubMed ID: 7268897
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of five cloned murine cell lines showing high cytolytic activity against YAC-1 cells.
    Brooks CG; Kuribayashi K; Sale GE; Henney CS
    J Immunol; 1982 May; 128(5):2326-35. PubMed ID: 6174628
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells.
    Wright SC; Hiserodt JC; Bonavida B
    Transplant Proc; 1981 Mar; 13(1 Pt 2):770-3. PubMed ID: 7268895
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of murine natural killer cells by Cryptococcus neoformans.
    Bartizal KF; Salkowski CA; Balish E
    Prog Clin Biol Res; 1985; 181():333-6. PubMed ID: 3895239
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice.
    Brenner GJ; Cohen N; Moynihan JA
    Cell Immunol; 1994 Sep; 157(2):510-24. PubMed ID: 8069930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors.
    Riccardi C; Barlozzari T; Santoni A; Herberman RB; Cesarini C
    J Immunol; 1981 Apr; 126(4):1284-9. PubMed ID: 7204966
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration.
    Kumar V; Ben-Ezra J; Bennett M; Sonnenfeld G
    J Immunol; 1979 Oct; 123(4):1832-8. PubMed ID: 383842
    [No Abstract]   [Full Text] [Related]  

  • 8. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
    Kung SK; Miller RG
    J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal mouse NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro.
    Manoussaka MS; Smith RJ; Conlin V; Toomey JA; Brooks CG
    J Immunol; 1998 Mar; 160(5):2197-206. PubMed ID: 9498758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenocytes cultured in low concentrations of IL-2 generate NK cell specificities toward syngenic and allogenic targets.
    Nissen MH; Jeppesen M; Claesson MH
    Cell Immunol; 2000 Jul; 203(1):47-54. PubMed ID: 10915561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer activity of Wistar rat spleen cells: blocking effect of homologous sera.
    Lavrovsky VA; Viksler VK
    Immunology; 1980 Nov; 41(3):541-5. PubMed ID: 7461701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
    Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
    In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine antibody-dependent cell-mediated cytotoxicity: failure to detect effector cells equivalent to human K cells.
    Tada M; Hinuma S; Abo T; Kumagai K
    J Immunol; 1980 Apr; 124(4):1929-36. PubMed ID: 7365244
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive activity of monoclonal anti-thy-1.2: comparison of monoclonal IgM and IgG with xeno-antithymocyte preparations.
    Sherburne CG; Condie RM
    Transplant Proc; 1981 Mar; 13(1 Pt 1):504-8. PubMed ID: 6973851
    [No Abstract]   [Full Text] [Related]  

  • 19. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
    Weiss L; Reich S; Mandelboim O; Slavin S
    Bone Marrow Transplant; 2004 Jun; 33(11):1137-41. PubMed ID: 15077128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.